Catalyst Pharmaceuticals (CPRX) Cash from Investing Activities (QoQ) (2011 - 2026)
Catalyst Pharmaceuticals (CPRX) Cash from Investing Activities (QoQ) (2011 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Catalyst Pharmaceuticals |
3.84 Bn |
3.08 Bn |
134.92 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
15.63% |
| Dec 31, 2024 |
66.02% |
| Sep 30, 2024 |
-2,490.00% |
| Jun 30, 2024 |
94.97% |
| Mar 31, 2024 |
99.48% |
| Dec 31, 2023 |
58.72% |
| Dec 31, 2021 |
39.71% |
| Sep 30, 2021 |
98.30% |
| Jun 30, 2021 |
42.11% |
| Mar 31, 2020 |
-84.21% |
| Dec 31, 2019 |
527.28% |
| Sep 30, 2019 |
150.82% |
| Jun 30, 2019 |
-195.04% |
| Mar 31, 2019 |
-26.12% |
| Dec 31, 2018 |
86.67% |
| Sep 30, 2018 |
252.91% |
| Jun 30, 2018 |
84.44% |
| Mar 31, 2018 |
-52,489.69% |
| Dec 31, 2017 |
303.73% |
| Sep 30, 2017 |
-1,590.54% |
